分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Identification of cofilin-1 as a novel mediator for the metastatic potentials and chemoresistance of the prostate cancer cells

Liankuai Chen, Jialong Cai, Yishan Huang, Xiangpeng Tan, Qiuxiao Guo, Xiaomian Lin, Cairong Zhu, Xiangfeng Zeng, Hongjiao Liu, Xiaoping Wu

Journal:EUROPEAN JOURNAL OF PHARMACOLOGY

IF:3.26

DOI:10.1016/j.ejphar.2020.173100

PMID:32320704

Published:2020-04-19

research field:分子生物学免疫学遗传学眼科学

Abstract

Prostate cancer (PCa) is the most common malignancy among men. Tumor metastasis and chemoresistance contribute to the major cause of the mortality. In this study, we compared the protein profiles of two prostate cancer cell lines with different metastatic potentials , and identified cofilin-1 (CFL1) was one of the most differentially expressed proteins between two cell lines. Further results suggested that cofilin-1 promoted the remodeling of F-actin cytoskeleton, and enhanced the proliferation, migration and invasion of the prostate cancer cells via activation of P38 MAPK signaling pathway. In addition, cofilin-1 elevated the expression and drug efflux activity of multidrug resistance protein 1 (MDR1) by P38 MAPK signaling pathway, resulting in decrease of the adriamycin-induced apoptosis as well as the lytic cell death , and the subsequent resistance against adriamycin . Collectively, cofilin-1 might serve as a novel target candidate for both inhibiting the metastasis and reversing the chemoresistance of PCa.

本文使用的Yeasen产品

购物车
客服
转染试用